KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables - Other (2016)

Historic Receivables - Other for Bausch Health Companies (BHC) over the last 4 years, with Q4 2016 value amounting to $60.0 million.

  • Bausch Health Companies' Receivables - Other changed N/A to $60.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $60.0 million, marking a year-over-year change of. This contributed to the annual value of $60.0 million for FY2016, which is N/A changed from last year.
  • Per Bausch Health Companies' latest filing, its Receivables - Other stood at $60.0 million for Q4 2016.
  • In the past 5 years, Bausch Health Companies' Receivables - Other ranged from a high of $60.0 million in Q4 2016 and a low of $12.9 million during Q1 2012
  • For the 3-year period, Bausch Health Companies' Receivables - Other averaged around $18.1 million, with its median value being $12.9 million (2012).
  • The largest annual percentage gain for Bausch Health Companies' Receivables - Other in the last 5 years was 0.0% (2013), contrasted with its biggest fall of 0.0% (2013).
  • Bausch Health Companies' Receivables - Other (Quarter) stood at $12.9 million in 2012, then changed by 0.0% to $12.9 million in 2013, then surged by 365.12% to $60.0 million in 2016.
  • Its last three reported values are $60.0 million in Q4 2016, $12.9 million for Q4 2013, and $12.9 million during Q3 2013.